Numerous legal, policy and clinical changes have been made in an attempt to stem the tide of opioid overdose death and disability, including measures to increase access to naloxone, the medication that reverses overdose if given in time. As of July 1, 2017, every state and Washington D.C. has passed at least one law increasing access to naloxone—a remarkably rapid progression for public health legislation.
Since 1965, chlorpyrifos has been a commonly used pesticide, and nearly six million pounds of it are used domestically each year on more than fifty different types of crops. Scientists have linked the pesticide to harmful effects in children and adults, including developmental damage to children’s brains, reduced intelligence levels, loss of working memory, and attention deficit disorders. A proposed ban by the Environmental Protection Agency on the use of chlorpyrifos slated to go into effect in March, 2017 has been denied, leaving states to decide whether to take action to subject the pesticide to more stringent rules.
High rates of morbidity and mortality among Americans related to opioid use constitute a public health epidemic, leading multiple jurisdictions to declare formal states of emergency or public health emergency. Declaring a state of emergency grants states and localities additional resources to address the epidemic immediately. The Fact Sheet provides a brief summary of the emergency declarations in six states. The Primer provides a visual snapshot and synopses of state-and tribal-based emergency declarations across the U.S. based on currently-available information.
Wednesday, August 30 from 1:00 to 2:30 p.m. ET
Health care providers cite the Health Insurance Portability and Accountability Act (HIPAA) privacy rule to deny or limit access to patients’ private health information—sometimes appropriately, often not. This webinar will equip public health practitioners with HIPAA basics, terminology, myth busters, and strategies to maximize access to and increase the exchange of health information while maintaining the public’s trust.
Naloxone blocks or reverses the effects of opioids and can save the life of someone overdosing if given in a timely manner. A public health professional recently asked the Network if it is legal for a layperson to distribute naloxone injection equipment in Texas. And whether pharmacists in Texas are liable for selling injection equipment if they suspect the person will use it to inject drugs.
In an effort to address opioid overprescribing, policymakers have mounted a series of interventions meant to limit access to opioids. This article, co-authored by Corey Davis, Deputy Director and Staff Attorney at the Network’s Southeastern Region Office, draws on historical lessons of the era of National Alcohol Prohibition to highlight the unintended, but predictable impact of these types of supply-side interventions. The authors note that Intensive supply suppression of prescription opioids has created increased demand for alternatives like heroin and fentanyl. The focus must shift, they argue, from supply reduction to demand and harm reduction.
The Mid-States Region Office of the Network will provide legal technical assistance, consulting and recommendations related to data collection, use, sharing and protection for a project led by Michigan State University to establish a registry of Flint residents who were exposed to lead-contaminated water from the Flint Water System during 2014 – 2015. The project is funded by the U.S. Department of Health and Human Services.
The Network has an opening for a part-time Program Development Coordinator. This position is responsible for supporting program and fundraising activities for the Network. The Program Development Coordinator must have the ability to work collaboratively within project teams, and interact effectively with staff, leadership, consultants, members, funders and sponsors. This position provides project development, management and administrative support as assigned, and reports to the Program Manager.